Comprehensive Cancer Center

Palm Springs, California 982262

0 studies enrolling now · 13 studies all time

What they study most

Breast Cancer, Gastric Cancer, Hormone Receptor Positive Malignant Neoplasm of Breast, Mantle Cell Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin's Lymphoma, Palmar-Plantar Erythrodysesthesia, Peripheral T-cell Lymphoma, Prostate Cancer, Small Cell Lung Cancer, Unresectable Stage III or IV Malignant Melanoma

Studies at this site

• Connect® MM- The Multiple Myeloma Disease Registry — Stopped early
• A Safety and Efficacy Study in Patients With Gastric Cancer — Completed
• A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer — Completed
• Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma — Completed
• Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome — Completed
• Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010) — Completed
• Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer — Completed
• PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score — Completed
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed
• Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) — Completed
• Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer — Completed